Financials

  • Market Capitalization 730.42 M
  • Employee 61
  • Founded 2006
  • CEO N/A
  • Website www.zevra.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZG1F5
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.26
ratio cours/chiffre d'affaires
6.21

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2647
PHAT
Phathom Pharmaceuticals, Inc. - Common Stock
9.26 USD-1.38%+5.59%+4.40%-22.70%749.14 M USD
2650
ASMB
Assembly Biosciences, Inc. - Common Stock
36.72 USD+4.38%+2.31%+43.83%+24.79%747.64 M USD
2679
VSTM
Verastem, Inc. - Common Stock
8.02 USD+5.39%+8.82%+42.20%-16.37%726.32 M USD
2688
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.89 USD+0.79%-3.26%+7.50%-11.98%712.75 M USD

Nouvelles